A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects

NCT07560033 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: CM326(formulation 1)
DRUG: CM326(formulation 2)

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.